Class of pharmaceuticals targeting HIV replication through various mechanisms including reverse transcriptase and protease inhibition. Bulk manufactured by global pharma entities, traded via B2B platforms to hospitals, AIDS service organizations, and procurement consortia for therapeutic and prophylactic applications.